Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Internship and Residency | 3 | 2023 | 1252 | 1.150 |
Why?
|
| Urinary Catheters | 1 | 2024 | 27 | 0.850 |
Why?
|
| Teaching Rounds | 1 | 2023 | 33 | 0.800 |
Why?
|
| Prostatitis | 1 | 2023 | 16 | 0.800 |
Why?
|
| Congresses as Topic | 1 | 2024 | 189 | 0.780 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2023 | 92 | 0.780 |
Why?
|
| Catheter-Related Infections | 1 | 2024 | 137 | 0.750 |
Why?
|
| Communicable Diseases | 1 | 2023 | 160 | 0.680 |
Why?
|
| Education, Medical, Graduate | 2 | 2023 | 564 | 0.670 |
Why?
|
| Urinary Tract Infections | 1 | 2024 | 317 | 0.630 |
Why?
|
| Thrombocytopenia | 1 | 2021 | 234 | 0.630 |
Why?
|
| Cyclonic Storms | 2 | 2017 | 79 | 0.620 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 297 | 0.620 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 198 | 0.610 |
Why?
|
| Containment of Biohazards | 1 | 2018 | 4 | 0.600 |
Why?
|
| Lassa virus | 1 | 2018 | 23 | 0.590 |
Why?
|
| Lassa Fever | 1 | 2018 | 12 | 0.590 |
Why?
|
| Education, Medical | 1 | 2022 | 303 | 0.590 |
Why?
|
| Contact Tracing | 1 | 2018 | 56 | 0.560 |
Why?
|
| Students, Medical | 1 | 2022 | 362 | 0.550 |
Why?
|
| Travel | 1 | 2018 | 125 | 0.540 |
Why?
|
| Thrombosis | 1 | 2021 | 529 | 0.510 |
Why?
|
| Fumigation | 1 | 2015 | 1 | 0.480 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2015 | 6 | 0.480 |
Why?
|
| Housing | 1 | 2015 | 54 | 0.470 |
Why?
|
| Aging | 1 | 2020 | 1261 | 0.410 |
Why?
|
| Psychometrics | 1 | 2017 | 693 | 0.410 |
Why?
|
| Environmental Exposure | 1 | 2015 | 236 | 0.400 |
Why?
|
| New Jersey | 5 | 2018 | 25 | 0.390 |
Why?
|
| Humans | 27 | 2024 | 132348 | 0.310 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 3087 | 0.270 |
Why?
|
| Cyclin-Dependent Kinase 9 | 2 | 2004 | 29 | 0.270 |
Why?
|
| Curriculum | 2 | 2022 | 765 | 0.260 |
Why?
|
| Cardiology | 2 | 2022 | 497 | 0.260 |
Why?
|
| Tuberculosis | 2 | 2024 | 559 | 0.250 |
Why?
|
| Pandemics | 2 | 2023 | 1188 | 0.230 |
Why?
|
| RNA Polymerase II | 2 | 2004 | 87 | 0.220 |
Why?
|
| Cyclins | 2 | 2004 | 100 | 0.220 |
Why?
|
| Latent Tuberculosis | 1 | 2024 | 76 | 0.210 |
Why?
|
| Cell Size | 1 | 2004 | 86 | 0.210 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2024 | 89 | 0.210 |
Why?
|
| Urinary Catheterization | 1 | 2024 | 87 | 0.210 |
Why?
|
| Consultants | 1 | 2023 | 11 | 0.200 |
Why?
|
| Cardiomegaly | 1 | 2004 | 125 | 0.200 |
Why?
|
| Blood Culture | 1 | 2023 | 36 | 0.190 |
Why?
|
| Infection Control | 1 | 2024 | 158 | 0.190 |
Why?
|
| Personal Satisfaction | 1 | 2023 | 105 | 0.190 |
Why?
|
| BK Virus | 1 | 2023 | 60 | 0.190 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2022 | 11 | 0.190 |
Why?
|
| Nephritis, Interstitial | 1 | 2023 | 40 | 0.190 |
Why?
|
| Polyomavirus Infections | 1 | 2023 | 91 | 0.190 |
Why?
|
| Internal Medicine | 1 | 2023 | 159 | 0.180 |
Why?
|
| Teaching | 1 | 2023 | 200 | 0.180 |
Why?
|
| Pneumonia, Pneumococcal | 2 | 2013 | 87 | 0.180 |
Why?
|
| Male | 11 | 2024 | 65061 | 0.170 |
Why?
|
| Shock, Septic | 1 | 2022 | 156 | 0.170 |
Why?
|
| Chronic Disease | 2 | 2023 | 1229 | 0.160 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 3980 | 0.160 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 38 | 0.160 |
Why?
|
| Aged | 8 | 2024 | 21381 | 0.150 |
Why?
|
| Referral and Consultation | 1 | 2023 | 569 | 0.150 |
Why?
|
| Liberia | 1 | 2018 | 8 | 0.150 |
Why?
|
| Inpatients | 1 | 2023 | 553 | 0.150 |
Why?
|
| Murinae | 1 | 2018 | 10 | 0.150 |
Why?
|
| Disease Reservoirs | 1 | 2018 | 36 | 0.150 |
Why?
|
| Diagnostic Errors | 1 | 2022 | 348 | 0.140 |
Why?
|
| Public Health Surveillance | 1 | 2018 | 44 | 0.140 |
Why?
|
| Fatal Outcome | 1 | 2018 | 377 | 0.140 |
Why?
|
| Meningitis, Meningococcal | 1 | 2017 | 14 | 0.140 |
Why?
|
| Neisseria meningitidis, Serogroup B | 1 | 2017 | 7 | 0.130 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2017 | 50 | 0.130 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 569 | 0.130 |
Why?
|
| Meningococcal Vaccines | 1 | 2017 | 30 | 0.130 |
Why?
|
| Middle Aged | 7 | 2024 | 28891 | 0.130 |
Why?
|
| Cognition | 1 | 2022 | 814 | 0.130 |
Why?
|
| Adolescent | 4 | 2020 | 20553 | 0.130 |
Why?
|
| Endocarditis, Bacterial | 1 | 2018 | 137 | 0.130 |
Why?
|
| Universities | 1 | 2017 | 129 | 0.130 |
Why?
|
| Adult | 6 | 2024 | 31619 | 0.130 |
Why?
|
| Disasters | 1 | 2017 | 105 | 0.120 |
Why?
|
| Vaccination | 1 | 2021 | 1017 | 0.120 |
Why?
|
| Heart Transplantation | 1 | 2023 | 875 | 0.120 |
Why?
|
| United States Virgin Islands | 1 | 2015 | 2 | 0.120 |
Why?
|
| Young Adult | 3 | 2020 | 9945 | 0.120 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2019 | 413 | 0.120 |
Why?
|
| Clinical Competence | 1 | 2022 | 1071 | 0.110 |
Why?
|
| Public Health | 1 | 2017 | 282 | 0.110 |
Why?
|
| Cause of Death | 1 | 2017 | 503 | 0.110 |
Why?
|
| Feces | 1 | 2018 | 780 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 1061 | 0.110 |
Why?
|
| Cluster Analysis | 1 | 2015 | 436 | 0.110 |
Why?
|
| Macrolides | 1 | 2013 | 30 | 0.100 |
Why?
|
| Female | 8 | 2024 | 70795 | 0.100 |
Why?
|
| Advisory Committees | 2 | 2022 | 151 | 0.090 |
Why?
|
| Necrosis | 1 | 2011 | 210 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 2557 | 0.090 |
Why?
|
| American Heart Association | 2 | 2022 | 309 | 0.080 |
Why?
|
| Neoplasms | 1 | 2024 | 2946 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 1541 | 0.080 |
Why?
|
| Streptococcus pneumoniae | 1 | 2011 | 381 | 0.080 |
Why?
|
| Retrospective Studies | 6 | 2024 | 17364 | 0.070 |
Why?
|
| Bacteremia | 1 | 2011 | 428 | 0.070 |
Why?
|
| Cyclin T | 2 | 2004 | 33 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 742 | 0.060 |
Why?
|
| Disease Outbreaks | 2 | 2018 | 329 | 0.060 |
Why?
|
| Risk Factors | 2 | 2017 | 10911 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2020 | 14857 | 0.060 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2004 | 86 | 0.050 |
Why?
|
| Blood Coagulation Tests | 1 | 2023 | 62 | 0.050 |
Why?
|
| Biomechanical Phenomena | 1 | 2004 | 261 | 0.050 |
Why?
|
| Animals | 3 | 2018 | 34995 | 0.050 |
Why?
|
| United States | 3 | 2022 | 11628 | 0.050 |
Why?
|
| Educational Status | 1 | 2022 | 295 | 0.040 |
Why?
|
| Child | 1 | 2020 | 25827 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2004 | 1615 | 0.040 |
Why?
|
| Myocardium | 1 | 2004 | 908 | 0.040 |
Why?
|
| Incidence | 2 | 2019 | 3362 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2022 | 513 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 332 | 0.030 |
Why?
|
| Death Certificates | 1 | 2017 | 10 | 0.030 |
Why?
|
| Heart | 1 | 2022 | 699 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2022 | 1076 | 0.030 |
Why?
|
| Leukemia | 1 | 2019 | 373 | 0.030 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 294 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2017 | 273 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 1331 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2017 | 325 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2004 | 2494 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1964 | 0.030 |
Why?
|
| Hospitalization | 1 | 2022 | 1894 | 0.030 |
Why?
|
| Serotyping | 1 | 2011 | 178 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2013 | 205 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2004 | 4725 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 1192 | 0.020 |
Why?
|
| Texas | 1 | 2019 | 3629 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2011 | 153 | 0.020 |
Why?
|
| Heart Failure | 1 | 2004 | 2386 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 956 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2013 | 488 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 7111 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 2187 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 2931 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 892 | 0.010 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2004 | 6 | 0.010 |
Why?
|
| Nuclear Respiratory Factors | 1 | 2004 | 7 | 0.010 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 2004 | 8 | 0.010 |
Why?
|
| Lung | 1 | 2011 | 1555 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 13017 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2169 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 618 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2004 | 714 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 1294 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 1564 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 1426 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 652 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 3062 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 3620 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 1904 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1997 | 0.010 |
Why?
|
| Mice | 1 | 2004 | 18572 | 0.000 |
Why?
|